glp-1 pharmaceuticals Drugs: Fighting Diabetes and Weight Gain๐ - General 1 pathway Comparing Ozempic, Wegovy and Other
Description
2021 Mok J, Adeleke MO, Brown A, Magee CG, Firman C, Makahamadze C, et al
doi: 10.1111/acel.12446
Peptides are small but mighty
For the bigger-picture philosophy, see GLP-1 microdosing explained
The patient who developed allodynia on tirzepatide 15 mg was successfully switched to oral semaglutide 14 mg without recurrence
